source
- Scancell to merge into Neuphoria and seek $89 million equity as AstraZeneca's breast cancer drug gains EU approvalScancell announced it will merge into Neuphoria Therapeutics, taking over Neuphoria's Nasdaq listing ($NEUP) and planning to change the ticker to SCLT. The combined entity aims to raise up to $89 m…
- BeOne invests $300 million in New Jersey plant, adding small-molecule capacity and 120 jobsBeOne Medicines announced a $300 million investment to expand its manufacturing campus in Hopewell, New Jersey. The expansion will include a three‑story, 145,000‑square‑foot building for small‑mol…